Related Experiment Video
Updated: Aug 5, 2026

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay
Published on: January 8, 2012
Management of gestational trophoblastic disease in developing countries
1Department of Obstetrics and Gynaecology, University of Malaya, 50603 Kuala Lumpur, Malaysia. sivanes@um.edu.my
Gestational trophoblastic neoplasia (GTN) management in Malaysia highlights chemotherapy as key, especially for invasive moles and high-risk cases. Selective preventive chemotherapy is advised for patients with unsatisfactory hCG regression, improving outcomes.
Area of Science:
- Obstetrics and Gynecology
- Oncology
- Reproductive Medicine
Background:
- Molar pregnancy and gestational trophoblastic neoplasia (GTN) incidence in Malaysia is significant, with variations across ethnic groups.
- Hydatidiform mole evacuation requires careful follow-up, as partial moles are potentially malignant.
- Gestational trophoblastic neoplasia (GTN) management necessitates timely intervention, particularly in cases of invasive moles with metastases or hCG non-regression.
Purpose of the Study:
- To review the epidemiology and management strategies for molar pregnancy and gestational trophoblastic neoplasia (GTN) in Malaysia.
- To evaluate the effectiveness of different treatment modalities for gestational trophoblastic neoplasia (GTN).
- To identify risk factors and stratify patients for optimal treatment outcomes in gestational trophoblastic neoplasia (GTN).
Main Methods:
- Retrospective analysis of patient data on molar pregnancy and gestational trophoblastic neoplasia (GTN) in Malaysia.
- Review of treatment protocols including uterine evacuation, chemotherapy, surgery, and radiotherapy.
- Risk stratification based on tumor bulk and disease location.
Main Results:
- The incidence of molar pregnancy and gestational trophoblastic neoplasia (GTN) is 2.8 and 1.59 per 1000 deliveries, respectively, with higher prevalence in the Chinese population.
- Complete evacuation of hydatidiform mole is not always achieved in the first attempt (25% of cases).
- Chemotherapy is the primary treatment for gestational trophoblastic neoplasia (GTN), with survival rates of 100% (low-risk), 98% (medium-risk), and 61.7% (high-risk).
Conclusions:
- Selective preventive chemotherapy is recommended for 'at-risk' patients with unsatisfactory hCG regression curves.
- Chemotherapy is the mainstay of gestational trophoblastic neoplasia (GTN) treatment, with risk stratification guiding management.
- Surgery and radiotherapy play a limited role in the overall management of gestational trophoblastic neoplasia (GTN).
More Related Videos
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Toxoplasmosis
American Trypanosomiasis